Many families face the challenge of drug-resistant epilepsy, questioning the transition from medication to surgery.

A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy. In clinical trials, the treatment zorevunersen cut seizures by as much as 91 ...

A pioneering gene therapy could help treat a rare seizure disorder called Dravet syndrome, according to new clinical trial ...

A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, ...

Epilepsy is one of the most common diseases affecting the nervous system and implies a predisposition to seizures. Per best estimates from CDC and WHO, there are 3.4 million people living with ...

A new drug is transforming the lives of children born with a severe form of epilepsy, say doctors and families. Dravet syndrome can cause dozens of dangerous seizures a day and affects about one in ...

Professor of Pathology, Lee J. Martin, discusses the prevalence and treatment challenges associated with hypoxic-ischemic encephalopathy (HIE) ...

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, ...

An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and ...

A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping them lead much healthier and happier lives, the findings of a UCL ...